European Union and EDCTP strategy in the global context

Recommendations for preventive HIV/AIDS vaccines research

Thomas Lehner, Michael Hoelscher, Mario Clerici, Frances Gotch, Louise Pedneault, Jim Tartaglia, Clive Gray, Jiri Mestecky, Quentin Sattentau, Janneke Van De Wijgert, Coumba Toure, Saladin Osmanov, Reinold E. Schmidt, Patrice Debre, Manuel Romaris, Arnd Hoeveler, Simonetta Di Fabio

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations.

Original languageEnglish
Pages (from-to)5551-5556
Number of pages6
JournalVaccine
Volume23
Issue number48-49
DOIs
Publication statusPublished - Dec 1 2005

Fingerprint

AIDS Vaccines
European Union
Developing Countries
developing countries
clinical trials
Clinical Trials
vaccines
selection criteria
Research
Patient Selection
HIV
virology
Virology
vaccine development
Allergy and Immunology
immunology
committees
epidemiology
Acquired Immunodeficiency Syndrome
Epidemiology

Keywords

  • European Commission Strategy
  • HIV/AIDS
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

European Union and EDCTP strategy in the global context : Recommendations for preventive HIV/AIDS vaccines research. / Lehner, Thomas; Hoelscher, Michael; Clerici, Mario; Gotch, Frances; Pedneault, Louise; Tartaglia, Jim; Gray, Clive; Mestecky, Jiri; Sattentau, Quentin; Wijgert, Janneke Van De; Toure, Coumba; Osmanov, Saladin; Schmidt, Reinold E.; Debre, Patrice; Romaris, Manuel; Hoeveler, Arnd; Di Fabio, Simonetta.

In: Vaccine, Vol. 23, No. 48-49, 01.12.2005, p. 5551-5556.

Research output: Contribution to journalArticle

Lehner, T, Hoelscher, M, Clerici, M, Gotch, F, Pedneault, L, Tartaglia, J, Gray, C, Mestecky, J, Sattentau, Q, Wijgert, JVD, Toure, C, Osmanov, S, Schmidt, RE, Debre, P, Romaris, M, Hoeveler, A & Di Fabio, S 2005, 'European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research', Vaccine, vol. 23, no. 48-49, pp. 5551-5556. https://doi.org/10.1016/j.vaccine.2005.07.009
Lehner, Thomas ; Hoelscher, Michael ; Clerici, Mario ; Gotch, Frances ; Pedneault, Louise ; Tartaglia, Jim ; Gray, Clive ; Mestecky, Jiri ; Sattentau, Quentin ; Wijgert, Janneke Van De ; Toure, Coumba ; Osmanov, Saladin ; Schmidt, Reinold E. ; Debre, Patrice ; Romaris, Manuel ; Hoeveler, Arnd ; Di Fabio, Simonetta. / European Union and EDCTP strategy in the global context : Recommendations for preventive HIV/AIDS vaccines research. In: Vaccine. 2005 ; Vol. 23, No. 48-49. pp. 5551-5556.
@article{956481dd52ce40ae85d0c5e0f37a11f3,
title = "European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research",
abstract = "The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations.",
keywords = "European Commission Strategy, HIV/AIDS, Vaccine",
author = "Thomas Lehner and Michael Hoelscher and Mario Clerici and Frances Gotch and Louise Pedneault and Jim Tartaglia and Clive Gray and Jiri Mestecky and Quentin Sattentau and Wijgert, {Janneke Van De} and Coumba Toure and Saladin Osmanov and Schmidt, {Reinold E.} and Patrice Debre and Manuel Romaris and Arnd Hoeveler and {Di Fabio}, Simonetta",
year = "2005",
month = "12",
day = "1",
doi = "10.1016/j.vaccine.2005.07.009",
language = "English",
volume = "23",
pages = "5551--5556",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "48-49",

}

TY - JOUR

T1 - European Union and EDCTP strategy in the global context

T2 - Recommendations for preventive HIV/AIDS vaccines research

AU - Lehner, Thomas

AU - Hoelscher, Michael

AU - Clerici, Mario

AU - Gotch, Frances

AU - Pedneault, Louise

AU - Tartaglia, Jim

AU - Gray, Clive

AU - Mestecky, Jiri

AU - Sattentau, Quentin

AU - Wijgert, Janneke Van De

AU - Toure, Coumba

AU - Osmanov, Saladin

AU - Schmidt, Reinold E.

AU - Debre, Patrice

AU - Romaris, Manuel

AU - Hoeveler, Arnd

AU - Di Fabio, Simonetta

PY - 2005/12/1

Y1 - 2005/12/1

N2 - The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations.

AB - The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations.

KW - European Commission Strategy

KW - HIV/AIDS

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=27744590448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744590448&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2005.07.009

DO - 10.1016/j.vaccine.2005.07.009

M3 - Article

VL - 23

SP - 5551

EP - 5556

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 48-49

ER -